Literature DB >> 1679258

Stroke therapy.

J A Zivin1, D W Choi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679258     DOI: 10.1038/scientificamerican0791-56

Source DB:  PubMed          Journal:  Sci Am        ISSN: 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  7 in total

1.  Therapeutic potential of umbilical cord blood stem cells on brain damage of a model of stroke.

Authors:  Mohammad Reza Nikravesh; Mehdi Jalali; Hossein Ali Ghafaripoor; Javad Sanchooli; Darioush Hamidi; Shabnam Mohammadi; Masoomeh Seghatoleslam
Journal:  J Cardiovasc Thorac Res       Date:  2011-12-28

Review 2.  Blockade of glutamate excitotoxicity and its clinical applications.

Authors:  K Hirose; P H Chan
Journal:  Neurochem Res       Date:  1993-04       Impact factor: 3.996

3.  Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau.

Authors:  Guanghong Liao; Miou Zhou; Simon Cheung; James Galeano; Nam Nguyen; Michel Baudry; Xiaoning Bi
Journal:  Brain Res       Date:  2008-11-01       Impact factor: 3.252

Review 4.  Neuroprotective therapies in stroke.

Authors:  J A Zivin
Journal:  Drugs       Date:  1997       Impact factor: 9.546

Review 5.  A Neurotoxic Ménage-à-trois: Glutamate, Calcium, and Zinc in the Excitotoxic Cascade.

Authors:  Alberto Granzotto; Lorella M T Canzoniero; Stefano L Sensi
Journal:  Front Mol Neurosci       Date:  2020-11-26       Impact factor: 5.639

6.  Long-Term Dynamic Changes of NMDA Receptors Following an Excitotoxic Challenge.

Authors:  Alberto Granzotto; Marco d'Aurora; Manuela Bomba; Valentina Gatta; Marco Onofrj; Stefano L Sensi
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

7.  Editorial: Excitotoxicity Turns 50. The Death That Never Dies.

Authors:  Alberto Granzotto; John H Weiss; Stefano L Sensi
Journal:  Front Neurosci       Date:  2022-01-17       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.